| Vessel
Wall Imaging Ballroom B Chairs: Zahi Adel Fayad and Thomas M. Grist |
| 16:30 80. In Vivo MR Characterization of Human Aortic Atherosclerotic Plaques, Z.A. Fayad, T. Nahar, J.T. Fallon, M. Goldman, J.G. Aguinaldo, J.J. Badimon and V. Fuster, Mount Sinai School of Medicine, New York, NY, USA. |
| 16:42 81. MR Imaging of Atherosclerotic Plaque with Ultrasmall Super Paramagnetic Iron Oxide (USPIO) in Hyperlipidemic Rabbits, S.G. Ruehm, H.H. Quick, C. Corot, B. Marincek and J.F. Debatin, University Hospital, Zurich, Switzerland and Laboratoire Guerbet, Paris, France. |
| 16:54 82. Real-Time Intravascular Magnetic Resonance Receiver Probe: In Vivo Observations in the Rabbit Aorta, P.A. Rivas, M.V. McConnell, K. Nayak, G. Scott, C. Meyer, J.M. Pauly, D.G. Nishimura, A. Macovski and B.S. Hu, Stanford University, Stanford, CA, USA. |
| 17:06 83. Multispectral Analysis of MR Images of Atherosclerotic Plaque: Correlation with Histology, S. Clarke, B. Rutt, S. Lownie, R. Hammond and J.R. Mitchell, of Western Ontario, John P. Robarts Research Institute and London Health Sciences Centre, London, Ontario, Canada. |
| 17:18 84. A T2 Classification for the Discrimination of Atheromatous Primary and Restenotic Coronary Plaques at 1.5T by High-Resolution MRI, J-F. Toussaint, H. Gouya, D. Glutron, P. Fornès, G. Berger, M. Paillard and J. Bittoun, Broussais Hospital and Bicêtre Hospital, Paris, France. |
| 17:30 85. Lesion Index: A Quantitative Measure of Atherosclerotic Lesion Complexity and Progression in MR Images, C. Yuan, X. Kang, D. Xu and T.S. Hatsukami, University of Washington, Seattle, WA, USA. |
| 17:42 86. 3D MRI of Atherosclerosis Progression in Transgenic Mice, P.D. Hockings, T.J. Roberts, D.G. Reid, M. Vidgeon-Hart, P.H.E. Groot, K.E. Suckling and G.M. Benson, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, UK. |
| 17:54 87. Lumen Size Measurement in MR Angiography, O.S. Aassar, A. Troyer, R. van Tyen, D. Saloner and the ACSCEPT Investigators, VA Medical Center, San Francisco, USA. |
| 18:06 88. Angiographic Determination of Vessel Distensibility In Vivo: Effects of Eprosartan (AII Antagonist) in a Severe Hypertension Model, S. Chandra, R.N. Willette, C.F. Sauermelch, S. Heron, F.C. Barone, E.H. Ohlstein and S.K. Sarkar, SmithKline Beecham Pharmaceuticals, King of Prussia, PA, USA. |
| 18:18 89. Estimation of Compliance in Aortic Aneurysms Using Pulse Wave Velocity Measurements, J.M. Boese, S.O. Schoenberg, M. Bock, F. Kallinowski, K. Gaase, M.V. Knopp and L.R. Schad, Deutsches Krebsforschungszentrum (DKFZ) and Chirurgische Universitätsklinik, Heidelberg, Germany. |